Dexmedetomidine Prolongs Lidocaine Intravenous Regional Anesthesia in Rats by Blocking the Hyperpolarization-Activated Cation Current
DOI: https://doi.org/10.2147/dddt.s450971
IF: 4.3188
2024-04-09
Drug Design Development and Therapy
Abstract:Tongtong Zhang, 1, &ast Xincheng Liao, 2, &ast Yuzhi Chen, 3, &ast Xinru Shu, 3 Deshan Liu, 4 Yusheng Yao 3, 5 1 Department of Anesthesiology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, People's Republic of China; 2 Department of Anesthesiology, The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, People's Republic of China; 3 Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, People's Republic of China; 4 Department of Neurology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, People's Republic of China; 5 Fujian Provincial Key Laboratory of Critical Care Medicine, Fuzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Deshan Liu; Yusheng Yao, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, 134, Dongjie Street, Fuzhou, 350001, People's Republic of China, Email ; Purpose: Intravenous regional anesthesia (IVRA) using lidocaine provides effective localized analgesia but its duration is limited. The mechanism by which dexmedetomidine enhances lidocaine IVRA is unclear but may involve modulation of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. Materials and Methods: Lidocaine IVRA with varying dexmedetomidine concentrations was performed in the tails of Sprague-Dawley rats. Tail-flick and tail-clamping tests assessed IVRA analgesia and anesthesia efficacy and duration. Contributions of α 2 adrenergic receptors and HCN channels were evaluated by incorporating an α adrenergic receptor antagonist, the HCN channel inhibitor ZD7288, and the HCN channel agonist forskolin. Furthermore, whole-cell patch clamp electrophysiology quantified the effects of dexmedetomidine on HCN channels mediating hyperpolarization-activated cation current (I h ) in isolated dorsal root ganglion neurons. Results: Dexmedetomidine dose-dependently extended lidocaine IVRA duration and analgesia, unaffected by α 2 receptor blockade. The HCN channel inhibitor ZD7288 also prolonged lidocaine IVRA effects, while the HCN channel activator forskolin shortened effects. In dorsal root ganglion neurons, dexmedetomidine concentration-dependently inhibited I h amplitude and shifted the voltage-dependence of HCN channel activation. Conclusion: Dexmedetomidine prolongs lidocaine IVRA duration by directly inhibiting HCN channel activity, independent of α 2 adrenergic receptor activation. This HCN channel inhibition represents a novel mechanism underlying the anesthetic and analgesic adjuvant effects of dexmedetomidine in IVRA. Keywords: dexmedetomidine, hyperpolarization-activated cyclic nucleotide-gated channel, intravenous regional anesthesia, lidocaine Intravenous regional anesthesia (IVRA) is a widely used to rapidly induce localized anesthesia for outpatient procedures on the extremities. 1–3 Among available agents, lidocaine is the preferred option for IVRA due to its rapid onset, tourniquet compatibility, and adequate safety profile. 4,5 However, the routine application of lidocaine IVRA is limited by its relatively short duration. Incorporating adjuvants can prolong the anesthetic effect, overcoming this limitation. 6,7 Dexmedetomidine, a highly selective α 2 -adrenergic agonist, is commonly used as an adjuvant in IVRA to prolong analgesia duration. 8,9 The mechanism was initially attributed to α 2 receptor activation, leading to reduced neuronal excitability. 10,11 However, recent evidence indicates that dexmedetomidine may also act by blocking hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. A study on perineural dexmedetomidine for sciatic nerve block found that analgesia extension occurred independently of α 2 agonism, implicating HCN channel inhibition. 12 This has been corroborated by other nerve block studies using α 2 agonists. 13 HCN channels mediate hyperpolarization-activated cation current (I h ), which regulates neuronal resting membrane potential. 14,15 Inhibiting HCN channels could induce sustained hyperpolarization to extend the time of action of local anesthetics. 16 While modulation of HCN channels underlies some effects of dexmedetomidine, its specific interaction in the context of IVRA has not yet been fully elucidated. This preclinical study explores the relatively -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal